CDTX icon

Cidara Therapeutics
CDTX

Overview Fund Activity

46 hedge funds and large institutions have $153M invested in Cidara Therapeutics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
10
Increased
14
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BB
1
BB Biotech
Switzerland
$8.01M
2
Goldman Sachs
2
Goldman Sachs
New York
$9.37M
3
EAM
3
Eventide Asset Management
Massachusetts
$4.53M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.31M
5
SIM
5
Spark Investment Management
New York
$564K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
DM
2
Deerfield Management
New York
$2.05M
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$33.7M
5
BA
5
BlackRock Advisors
Delaware
$22K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
51
Citadel Advisors
Florida
– -$310K -1,220 Closed
BlackRock
52
BlackRock
New York
– -$113K -444 Closed
SEI Investments
53
SEI Investments
Pennsylvania
– -$104K -411 Closed
UBS Group
54
UBS Group
Switzerland
– -$12K -49 Closed
SFPIA
55
Stevens First Principles Investment Advisors
California
– -$10K -40 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
– -$4K -15 Closed
1 2
3